Damian Garde
It's been a busy month for Retrophin, and CEO Martin Shkreli is capping it off with an IPO filing, looking to take his company from over-the-counter trading to the ...
Carly Helfand
GlaxoSmithKline's Advair is not your average off-patent blockbuster. It's difficult to copy, which has held off any major generic competition to date. Now, Novartis' ...
mia.burns
By Mia Burns (mia.burns@ubm.com)
Close to 16 percent, or 37 million of adults agree that paying more for branded prescription medications rather than getting generic products, ...
Damian Garde
Hackers have found their way into the FDA's data vaults on investigational drugs, and industry groups are urging the agency to undergo a third-party audit to make sure ...
Eric Palmer
Hackers got into FDA computer systems recently, prompting the agency to warn drugmakers to be on the lookout for misuse of their credit and to change their passwords. But ...
barbara.lempert
Onconova Announces Results of Interim Analysis of Metastatic Pancreatic Cancer Study
NEWTOWN, Pa., Dec. 17, 2013 (GLOBE NEWSWIRE) — Onconova Therapeutics, Inc. ...
Damian Garde
GlaxoSmithKline and Theravance scored another victory through their profitable partnership, winning FDA approval for Anoro Ellipta, a trailblazing COPD combo therapy with ...
esilverman
Just a few months after Pfizer tapped general counsel Amy Schulman to head one of three so-called innovative business units that are supposed to take shape in January ...
Damian Garde
Onconova Therapeutics' shares took a 16% beating Tuesday night after the company's top prospect, rigosertib, failed a Phase III trial in patients with pancreatic ...
Carly Helfand
The difference between magnesium salt and strontium salt may be enough to threaten U.S. sales of AstraZeneca's blockbuster Nexium–starting now. Reports say South ...
Tracy Staton
Shanghai Pharma, one of China's largest drugmakers, said it is investigating whistleblower claims that it bribed hospital staffers to amp up sales of its drugs. According ...
esilverman
For parents who worry those ADHD pills may not be appropriate, here is another reason for concern – the FDA has just issued a notice saying methylphenidate products, ...